Press Release

AHN's urogynecology program offers comprehensive care for pelvic floor disorders, breaking barriers with tailored treatment plans for women's health.

The FDA decision on berdazimer gel, 10.3%, represents the second approved treatment for the viral-borne skin disease.

This phase 3 program was advised to discontinue given that cobitolimod was shown to be less likely to meet its primary endpoint.

This announcement by Arcutis broadens the psoriasis drug’s indication and was done to help simplify management of the skin condition for younger patients as well.

The new educational initiative was launched to provide useful insights from dermatologists as well as personal accounts by patients with seborrheic dermatitis with many different backgrounds.

This new data had both a consistent long-term safety and tolerability profile with the previous short-term results for the skin disease, and there were no new safety signals recorded.

In these preliminary results from the ongoing POSITIVE study, tildrakizumab was shown to have led to significant improvement for psoriasis patients.

Beginning next year, the content, staff and experts from Practical Cardiology, Endocrinology Network and Rheumatology Network will be joining HCPLive.

CB Insights has announced the fourth annual Digital Health 150.

As the weather warms and spring turns to summer, the layers of clothing come off. It’s the time of year when people ramp up their diet and exercise regimens to tighten up that beach body.

Northwell Health is testing laser ablation for temporal lobe epilepsy.

Dr. Raju will serve as community health investment officer for New York’s largest health provider

Hahnemann University Hospital has launched the Gender Reassignment Surgical Program – a new gender affirmation program for transgender patients. Hahnemann will offer both female-to-male and male-to-female gender confirming surgeries.

The once-daily vaginal insert was found safe and effective in reducing vulvar and vaginal atrophy pain from intercourse. This is the first drug appoved by the FDA that contains its active ingredient, dehydroepiandrosterone.

MD Magazine, the leading online and print source of physician news, conference coverage, and peer-to-peer discussion, today announced that it has added Philadelphia-based Hahnemann University Hospital to its growing roster of Strategic Alliance Partners (SAP).

MD Magazine, an online and print publication with a national physician readership, surveyed 1,700 U.S. physicians (928 of whom responded) and found that 55.34 percent said they own guns, with about two-thirds of those respondents saying they use their weapon primarily for personal protection.

New MJH & Associates unit will focus on targeted therapies for cancer and other diseases

Pharmacy Times publishes a new journal for the growing specialty pharmacy market with prestigious editorial board and industry leaders.